APLT vs. MRUS

In the year-to-date period, APLT achieves a -58.74% return, which is significantly lower than MRUS's 33.34% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Applied Therapeutics, Inc. (APLT) and Merus N.V. (MRUS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current APLT Sharpe Ratio is -0.66, which is lower than the MRUS Sharpe Ratio of -0.04. The chart below compares the historical Sharpe Ratios of APLT and MRUS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither APLT nor MRUS has paid dividends to shareholders.

The maximum APLT drawdown since its inception was -99.45%, which is greater than MRUS's maximum drawdown of -67.42%. Use the drawdown chart below to compare losses from any high point for APLT and MRUS.

Applied Therapeutics, Inc. (APLT) has a higher volatility of 46.94% compared to Merus N.V. (MRUS) at 35.98%. This indicates that APLT's price experiences larger fluctuations and is considered to be riskier than MRUS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Applied Therapeutics, Inc. and Merus N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.